CoChat

Prediction of progression from mild cognitive impairment to Alzheimer's disease with longitudinal and multimodal data

Open access

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Abstract

Introduction: Accurate prediction of the progression from mild cognitive impairment (MCI) to Alzheimer's disease (AD) within a certain time frame is crucial for appropriate therapeutic interventions. However, it is challenging to capture the dynamic changes in cognitive and functional abilities over time, resulting in limited predictive performance. Our study aimed to investigate whether incorporating longitudinal multimodal data with advanced analytical methods could improve the capability to predict the risk of progressing to AD. Methods: This study included participants from the Alzheimer's Disease Neuroimaging Initiative (ADNI), a large-scale multi-center longitudinal study. Three data modalities, including demographic variables, neuropsychological tests, and neuroimaging measures were considered. A Long Short-Term Memory (LSTM) model using data collected at five-time points (baseline, 6, 12, 18, and 24-month) was developed to predict the risk of progression from MCI to AD within 2 years from the index exam (the exam at 24-month). In contrast, a random forest model was developed to predict the risk of progression just based on the data collected at the index exam. Results: The study included 347 participants with MCI at 24-month (age: mean 75, SD 7 years; 39.8% women) from ADNI, of whom 77 converted to AD over a 2-year follow-up period. The longitudinal LSTM model showed superior prediction performance of MCI-to-AD progression (AUC 0.93 ± 0.06) compared to the random forest model (AUC 0.90 ± 0.09). A similar pattern was also observed across different age groups. Discussion: Our study suggests that the incorporation of longitudinal data can provide better predictive performance for 2-year MCI-to-AD progression risk than relying solely on cross-sectional data. Therefore, repeated or multiple times routine health surveillance of MCI patients are essential in the early detection and intervention of AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/frdem.2023.1271680

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Sample selection diagram of this study.
Figure 1 Sample selection diagram of this study.CC BY · PubMed Central
Figure 2 The framework of the LSTM model.
Figure 2 The framework of the LSTM model.CC BY · PubMed Central
Figure 3 The ROC curves of LSTM and random forest models for predicting 2-year risk of progression from MCI to AD using three data modalities. The blue line represents the LSTM model (baseline, 6, 12, 18, and 24-month), which showed the best performance (AUC 0.93). The red line represents the random forest model with single time point data (24-month) (AUC 0.90).
Figure 3 The ROC curves of LSTM and random forest models for predicting 2-year risk of progression from MCI to AD using three data modalities. The blue line represents the LSTM model (baseline, 6, 12, 18, and 24-month), which showed the best performance (AUC 0.93). The red line represents the random forest model with single time point data (24-month) (AUC 0.90).CC BY · PubMed Central
Figure 4 The ROC curves of LSTM and random forest models with single modalities for predicting 2-year risk of progression from MCI to AD.
Figure 4 The ROC curves of LSTM and random forest models with single modalities for predicting 2-year risk of progression from MCI to AD.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. Schmidt, 1996, Rey Auditory Verbal Learning Test: a Handbook

Cited by

See all 32

Metadata

Authors
Ding, H., Wang, B., Hamel, A. P., Melkonyan, M., Ang, T. F. A., Au, R., & Lin, H.
Affiliations
  • Boston University (US)
  • University of Massachusetts Chan Medical School (US)
Corresponding author
Lin, Honghuang
Venue
Frontiers in Dementia
Published
2023-11-24
Volume
2
ISSN
2813-3919 (ISSN-L)
OpenAlex
W4388974203
Cited by
32
References
52
Citations by year
2026: 14 · 2025: 13 · 2024: 5
FWCI
6.52
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Dementia (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Institutes of Health (5u01ag024904-10, n01hc25195-41-0-1, 1r56ag062109-01)
  • National Institute on Aging (U01-AG-024904, U01AG068221, R01AG049810, R56-AG062109, RF1AG062109, R01AG016495, RF1AG054156, R01AG008122, U19AG068753, R01AG062109)
  • National Heart, Lung, and Blood Institute (N01-HC-025195)
  • National Institute of Neurological Disorders and Stroke (R01NS017950)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
Keywords
mild cognitive impairment, Alzheimer's disease, progression prediction, longitudinal data, multimodal data, LSTM, random forest, neuropsychological assessment, neuroimaging, early detection of dementia, ADNI

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.